{"id":1542,"date":"2023-05-11T13:18:32","date_gmt":"2023-05-11T13:18:32","guid":{"rendered":"https:\/\/innovationisrael.org.il\/en\/?post_type=kol_kore&p=1542"},"modified":"2023-05-23T08:23:04","modified_gmt":"2023-05-23T08:23:04","slug":"international-rd-and-pilots-collaboration-for-multinational-corporates-mncs-and-health-centers","status":"publish","type":"kol_kore","link":"https:\/\/innovationisrael.org.il\/en\/kol_kore\/international-rd-and-pilots-collaboration-for-multinational-corporates-mncs-and-health-centers\/","title":{"rendered":"International R&D and Pilots collaboration for Multinational Corporates (MNC\u2019s) and Health Centers"},"content":{"rendered":"\n

<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

<\/p>\n\n\n\n

Summary<\/h2>\n\n\n\n

The incentive program provides support to Israeli companies working with foreign companies on commercialization-directed programs to develop new technological products or to significantly upgrade an existing technology.
The program provides financial incentive funded by the Innovation Authority parallel to funding provided by foreign entities such as states, countries, provinces, and cities worldwide. The incentive program offers a financial grant that enables to share the risk in funding the project and assistance with finding foreign technology partners.<\/p>\n\n\n\n

Moreover, there is also the option to support Israeli companies\u2019 technological pilot programs in different fields, that will be conducted at selected foreign entities’ Beta sites or that will be based on their capabilities, data, or information. Products submitted as part of this incentive program must be ready for testing (after proof of feasibility and development of most of the product) and without additional significant R&D content.<\/p>\n\n\n\n

Relevant Technologies<\/h2>\n\n\n\n

All Technology Sectors<\/p>\n\n\n\n

Program Description<\/h2>\n\n\n\n

The Goal of this program is to encourage international collaborations between Israeli companies and international companies, leading health centers and MNC\u2019s to accelerate the availability of innovative products to crowd in the global markets.<\/p>\n\n\n\n

The Call for Proposals under this program will support large-scale R&D and\\or Pilot collaboration programs for up to 12 months.<\/p>\n\n\n\n

R&D programs<\/strong>:<\/p>\n\n\n\n

    \n
  1. Foreign companies in the Asia-Pacific region including: 
    China (China Ministry of Science & Technology) with the provinces: Guangdong (canceled at the request of the Guangdong), Shandong Science and Technology<\/a>, Shenzhen<\/a>, Zhejiang<\/a>, as well as Hong Kong<\/a> and Taiwan (DoIT\/ITRI)<\/a>, Thailand (NIA \u2013 National Agency of the Kingdom of Thailand)<\/a> and India (ANAND)<\/a> [for more details, watch this webinar<\/a>]<\/li>\n\n\n\n
  2. Foreign companies in South America: Colombia (INNPULSA)<\/a>, Argentina (MINCYT)<\/a><\/li>\n\n\n\n
  3. Foreign companies in the UK (Innovate UK<\/a>)<\/li>\n\n\n\n
  4. Health Centers (in the US): Jefferson<\/a>, Hartford<\/a>, Mayo Clinic<\/a>.<\/li>\n\n\n\n
  5. Multinational Corporates <\/li>\n\n\n\n
  6. EUREKA European Innovation Network<\/li>\n<\/ol>\n\n\n\n

    Pilot programs<\/strong>:<\/p>\n\n\n\n

      \n
    1. Foreign companies in the Asia-Pacific region including: 
      China (China Ministry of Science & Technology) with the provinces: Guangdong (Canceled at the request of Guangdong,       Shandong Science and Technology<\/a>, Shenzhen<\/a>, Zhejiang<\/a>, as well as Hong Kong <\/a>and Taiwan (DoIT\/ITRI)<\/a>, Thailand (NIA \u2013 National Agency of the Kingdom of Thailand)<\/a> and India (ANAND)<\/a><\/li>\n\n\n\n
    2. Foreign companies in South America: Colombia (INNPULSA)<\/a><\/li>\n\n\n\n
    3. Health Centers (in the US): Jefferson<\/a>, Hartford<\/a>, Mayo Clinic<\/a>.<\/li>\n\n\n\n
    4. Multinational Corporates <\/li>\n\n\n\n
    5. EUREKA European Innovation Network<\/li>\n<\/ol>\n\n\n\n

      Upon approval, Israeli companies will be entitled to 12 months of financial support and will be eligible for a second year of funding subject to a review of the project’s milestones.<\/strong><\/p>\n\n\n\n

      Criteria<\/h2>\n\n\n\n

      The preconditions and criteria for evaluation are detailed in Israel Innovation Authority\u2019s International Rules & Regulations and the R&D Fund Incentive program<\/a>. 
       <\/p>\n\n\n\n

      Funding<\/h2>\n\n\n\n

      The Israel Innovation Authority will provide support of 20% to 50% of the approved R&D budget of the Israeli companies, for a period of 12 months, according to the funding regulations.<\/p>\n\n\n\n

      Application Process<\/h2>\n\n\n\n

      The deadline for submission is \u200f19\/09\/22 at 12:00 noon (IST)<\/strong><\/p>\n\n\n\n